Novel Web-based, Self-directed Intervention for Chronic Pelvic Pain
2 other identifiers
interventional
70
1 country
1
Brief Summary
The study is being completed to evaluate the effectiveness of a web-based, self-management program for patients with Chronic Pelvic Pain (CPP). The overall hypothesis is that patients with chronic pelvic pain that have access to the My Pelvic Plan program will demonstrate improvements in pain, physical function, and quality of life with this integrative self-management approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2024
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedStudy Start
First participant enrolled
June 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2025
CompletedResults Posted
Study results publicly available
February 13, 2026
CompletedFebruary 13, 2026
January 1, 2026
7 months
April 2, 2024
January 27, 2026
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Short Form (SF) 4a Between Groups
There are four questions that participants will answer from not at all (1) - very much (5). The raw data was then converted to a t-score based on a population mean of 50 and standard deviation of 10, with higher scores above 50 meaning more interference and lower scores below 50 meaning less interference.
3 months
PROMIS Pain Intensity 1a Between Groups
There is one question that participants will answer no pain (0) - worst pain (10). The raw data was then converted to a t-score based on a population mean of 50 and standard deviation of 10, with higher scores above 50 meaning higher pain intensity and lower scores below 50 meaning lower pain intensity.
3 months
PROMIS Self Efficacy for Managing Symptoms SF 4a Between Groups
There are four questions that participants will answer from I am not all confident (1) - I am very confident (5). The raw data was then converted to a t-score based on a population mean of 50 and standard deviation of 10, with higher scores above 50 meaning more confidence in managing symptoms and lower scores below 50 meaning less confidence.
3 months
Secondary Outcomes (3)
Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Short Form (SF) 4a Between Groups
6 months
PROMIS Pain Intensity 1a Between Groups
6 months
PROMIS Self Efficacy for Managing Symptoms SF 4a Between Groups
6 months
Study Arms (2)
Monitoring progress plus usual care
OTHERParticipants will have access to the monitoring progress web-based symptom monitoring program.
My Pelvic Plan plus usual care
EXPERIMENTALParticipants will have access to My Pelvic Plan program.
Interventions
This is a self-directed program which integrates patient education about conditions that frequently contribute to pelvic pain, as well as instruction on cognitive and behavioral restructuring, self-administration of acupressure, engaging in physical activity, and a brief introduction to pelvic floor physical therapy techniques. Participants will have open access to the program over the 6-month intervention period. The intervention will be comprised of an active (12-week) phase and a maintenance (3-month) phase. Participants will receive a weekly text or email prompt directing patients to a specific module. All participants will receive prompts to the same modules for the first four weeks of the study, then during the next 8 weeks, participants will receive prompts to modules that corresponded to the most impactful symptoms on participant's baseline questionnaires. Following 12-week active phase, all participants will enter the maintenance phase.
Patients in the control group will undergo an active control intervention in which participants receive open access to a separate website that contains only the Monitoring Progress symptom tracker subpage over the 6-month study period. Control group participation will also be divided into an active (12-week) phase and a maintenance (3-month) phase. Similar to the intervention group, the control group will receive a weekly text (first 12 weeks) or email prompt directing them to a specific module or portion of the respective website. During the maintenance phase of the study, participants will receive monthly prompts to the Monitoring Progress subpage (without prompting to a specific symptom or activity).
Eligibility Criteria
You may qualify if:
- Participants have chronic pelvic pain, defined by the protocol for ≥ 6-month duration, and is non-cyclic, occurring for at least 14 days of each month.
- Must be currently receiving care within Department of Obstetrics and Gynecology at the University of Michigan for treatment of chronic pelvic pain
- Access to internet via computer or smartphone
- English-language proficiency (current version of the website is in English)
You may not qualify if:
- Underwent gynecologic surgery within 3 months of screening visit
- Plan to undergo gynecologic surgery within 6 months following screening visit
- Pregnant (self-reported) at time of screening visit. Will not exclude patients that become pregnant during the course of the study.
- Severe physical impairment precluding participating in internet-based program (for example, complete blindness or deafness)
- Current psychiatric disorder with history of psychosis (for example, schizophrenia, schizoaffective disorder, delusional disorder),
- Current suicidal ideation or suicide attempt within 2 years of screening visit. The study will screen for severe depression and suicidality at each questionnaire time point and have developed a robust triage and referral plan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sara Till
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Till, MD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Both participants and outcome assessors will be blinded to study group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Obstetrics and Gynecology
Study Record Dates
First Submitted
April 2, 2024
First Posted
April 8, 2024
Study Start
June 20, 2024
Primary Completion
January 23, 2025
Study Completion
April 28, 2025
Last Updated
February 13, 2026
Results First Posted
February 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share